BACKGROUND: Coronary artery disease (CAD) is a major cause of death in India. Data on outcome of CAD is scarce in the Indian population. This study determined the characteristics, treatment and one-year outcomes of acute coronary syndrome (ACS) in an Indian Cardiac Centre. METHODS: We carried out a cross sectional retrospective analysis of 1468 ACS patients hospitalized between January 2008 and December 2010 and followed up for 1 year in the Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai. Mortality at 1 year, its determinants and 1 year major adverse cardiac events (MACE) were determined. RESULTS: The patients were aged 62.2 ± 11.2 years; males (75.2%) and had ST segment elevation myocardial infarction (STEMI) (33.9%), non ST segment elevation myocardial infarction (44.2%) and unstable angina (21.9%). Key pharmacotherapy included aspirin (98.2%), clopidogrel (95.1%), statins (95.6%), angiotensin converting enzyme inhibitor/angiotensin receptor blocker (50.6%) and beta blocker (83.1%). Angiography rate was 80.6%. In the STEMI group, 53.3% had primary angioplasty, 20.3% were thrombolysed and 16.1% received sole medical therapy. Overall coronary artery bypass graft rate was 12.4%. At one year, all-cause mortality and composite MACE were 2.5% and 9.7%, respectively. MACE included death (2.5%), reinfarction (4.0%), resuscitated cardiac arrest (1.8%), stroke (1.1%) and bleeding (0.4%). Main factors associated with mortality were combined left ventricular systolic and diastolic dysfunction (OR = 20.0, 95% CI = 6.63-69.4) and positive troponin I (OR = 12.56, 95% CI = 1.78-25.23). Troponin I independently predicted mortality. CONCLUSIONS: ACS population was older than previously described in India. Evidence-based pharmacotherapy and interventions, and outcomes were comparable to the developed nations.
BACKGROUND:Coronary artery disease (CAD) is a major cause of death in India. Data on outcome of CAD is scarce in the Indian population. This study determined the characteristics, treatment and one-year outcomes of acute coronary syndrome (ACS) in an Indian Cardiac Centre. METHODS: We carried out a cross sectional retrospective analysis of 1468 ACS patients hospitalized between January 2008 and December 2010 and followed up for 1 year in the Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai. Mortality at 1 year, its determinants and 1 year major adverse cardiac events (MACE) were determined. RESULTS: The patients were aged 62.2 ± 11.2 years; males (75.2%) and had ST segment elevation myocardial infarction (STEMI) (33.9%), non ST segment elevation myocardial infarction (44.2%) and unstable angina (21.9%). Key pharmacotherapy included aspirin (98.2%), clopidogrel (95.1%), statins (95.6%), angiotensin converting enzyme inhibitor/angiotensin receptor blocker (50.6%) and beta blocker (83.1%). Angiography rate was 80.6%. In the STEMI group, 53.3% had primary angioplasty, 20.3% were thrombolysed and 16.1% received sole medical therapy. Overall coronary artery bypass graft rate was 12.4%. At one year, all-cause mortality and composite MACE were 2.5% and 9.7%, respectively. MACE included death (2.5%), reinfarction (4.0%), resuscitated cardiac arrest (1.8%), stroke (1.1%) and bleeding (0.4%). Main factors associated with mortality were combined left ventricular systolic and diastolic dysfunction (OR = 20.0, 95% CI = 6.63-69.4) and positive troponin I (OR = 12.56, 95% CI = 1.78-25.23). Troponin I independently predicted mortality. CONCLUSIONS: ACS population was older than previously described in India. Evidence-based pharmacotherapy and interventions, and outcomes were comparable to the developed nations.
Authors: K J Raihanathul Misiriya; N Sudhayakumar; S Abdul Khadar; Raju George; V L Jayaprakasht; Joseph M Pappachan Journal: J Assoc Physicians India Date: 2009-05
Authors: Mandeep Singh; Charanjit S Rihal; Bernard J Gersh; Veronique L Roger; Malcolm R Bell; Ryan J Lennon; Amir Lerman; David R Holmes Journal: J Am Coll Cardiol Date: 2008-06-17 Impact factor: 24.094
Authors: Jabir A; Anoop Mathew; Sunitha Viswanathan; Ashraf S M; Placid Sebastian; Prasannakumar C K; George Koshy A; Sunil Pisharody; Rony Mathew; L Jeyasheelan Journal: Indian Heart J Date: 2017-05-31
Authors: Simeon Isezuo; Mahmoud Umar Sani; Abdullahi Talle; Adeyemi Johnson; Abiodun-Moshood Adeoye; Mehmet S Ulgen; Amam Mbakwem; Okechukwu Ogah; Emmanuel Edafe; Philip Kolo; Murtala Nagabea; Rasaaq Adebayo; Eze Nwafor; Folasade Daniel; Muiyawa Zagga; Hayatu Umar; Isa Oboirien; Balarabe A Sulaiman; Umar Abdullahi; Muhammad Sani Mijinyawa; Farouk Buba; Akinyemi Aje; Henry Okolie; Muhammad Nazir Shehu; Umar Adamu; Akinsanya Olusegun-Joseph; Ranti Familoni; Nwuriku Chibuzor; Taiwo Olabisi Olunuga; Emmanuel Ejim; Awodu Rasheed Olaide; Dike Ojji; Bushra Sanni; Jane N Ajuluchukwu; Michael O Balogun; Ayodele B Omotoso; Mullasari Ajit; Ayodele O Falase Journal: J Am Heart Assoc Date: 2021-12-22 Impact factor: 6.106